A Phase 1, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics of HRS4800 in Healthy Subjects

NCT04991909 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain

Interventions

DRUG: HRS4800
DRUG: Placebo

Sponsor

Jiangsu HengRui Medicine Co., Ltd.